Literature DB >> 5289869

Radioimmunoassay of human fibrinopeptide A.

H L Nossel, L R Younger, G D Wilner, T Procupez, R E Canfield, V P Butler.   

Abstract

A radioimmunoassay capable of measuring 1 pmole of human fibrinopeptide A has been developed, and should prove useful to detect the release of this peptide from fibrinogen during the coagulation process. Antibodies to fibrinopeptide A were produced by injecting New Zealand white rabbits with a mixture of Freund's adjuvant and native fibrinopeptide coupled to human albumin. N-Tyrosyl fibrinopeptide A was synthesized by the solid-phase method, and was iodinated with (125)I by the Chloramine-T method. 48-73% of the radiolabeled peptide could be bound by the serum of a rabbit immunized with the fibrinopeptide-albumin preparation. Antibody-bound peptide was precipitated by dioxane and was thus separated from unbound peptide. The addition of excess native fibrinopeptide to the radiolabeled material prevented its binding to serum. Native fibrinopeptide A and synthetic fibrinopeptide A were identical in their ability to prevent binding, whereas fibrinogen was from 1/25,000 to 1/50,000 as effective on a weight basis. Plasma filtered through a membrane relatively impermeable to molecules larger than a molecular weight of 34,000 showed no fibrinopeptide reactivity, whereas a similar filtrate of serum gave quantitative recovery of fibrinopeptide reactivity.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5289869      PMCID: PMC389419          DOI: 10.1073/pnas.68.10.2350

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Hemostatic mechanisms in liver disease.

Authors:  O D RATNOFF
Journal:  Med Clin North Am       Date:  1963-05       Impact factor: 5.456

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  The clotting of fibrinogen. II. Fractionation of peptide material liberated.

Authors:  F R BETTELHEIM
Journal:  Biochim Biophys Acta       Date:  1956-01

4.  Fibrino-peptide.

Authors:  L LORAND
Journal:  Biochem J       Date:  1952-10       Impact factor: 3.857

5.  Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B.

Authors:  R H Herzig; O D Ratnoff; J R Shainoff
Journal:  J Lab Clin Med       Date:  1970-09

6.  Radioimmunoassay of bradykinin: chemical modification to enable use of radioactive iodine.

Authors:  T L Goodfriend; D L Ball
Journal:  J Lab Clin Med       Date:  1969-03

7.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

8.  Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?

Authors:  M Blombäck; B Blombäck; E F Mammen; A S Prasad
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

9.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

10.  Congenital dysfibrinogenemia: fibrinogen Detroit.

Authors:  E F Mammen; A S Prasad; M I Barnhart; C C Au
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

View more
  14 in total

1.  DIAGNOSTIC DEVELOPMENTS IN THROMBOTIC DISEASE.

Authors:  Sol Sherry
Journal:  Cardiovasc Dis       Date:  1975

2.  Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

Authors:  K A Bauer; L M Weiss; D Sparrow; P S Vokonas; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.

Authors:  M Cronlund; J Hardin; J Burton; L Lee; E Haber; K J Bloch
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 4.  Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer.

Authors:  J Kang; J Kambayashi; M Sakon; T Tsujinaka; T Mori
Journal:  Jpn J Surg       Date:  1989-05

5.  A sensitive latex agglutination method for the detection of soluble fibrin in plasma.

Authors:  U P Müller; R Largo; P W Straub
Journal:  Blut       Date:  1977-12

6.  Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.

Authors:  S B Bilezikian; H L Nossel; V P Butler; R E Canfield
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

7.  Intraoperative management of a dysfibrinogenemic patients with gastric cancer.

Authors:  T Tsujinaka; J Kambayashi; J Kang; M Sakon; T Mori
Journal:  Jpn J Surg       Date:  1988-01

8.  Generation of thrombin activity in relation to factor VIII:C concentrations and vascular complications in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S H Ibbotson; D Walmsley; J A Davies; P J Grant
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

9.  The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.

Authors:  H L Nossel; M Ti; K L Kaplan; K Spanondis; T Soland; V P Butler
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

10.  Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.

Authors:  K A Bauer; T L Goodman; B L Kass; R D Rosenberg
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.